Growth over 10 years following a 1-year trial of growth hormone therapy

@article{Rees2000GrowthO1,
  title={Growth over 10 years following a 1-year trial of growth hormone therapy},
  author={Lesley Rees and Gladys M. Ward and Susan P. A. Rigden},
  journal={Pediatric Nephrology},
  year={2000},
  volume={14},
  pages={309-314}
}
The growth of short children with chronic renal failure (CRF) and renal transplants was assessed over 10 years following entry into a 1-year trial of recombinant human growth hormone (rhGH) therapy. Patients were divided into three groups: 6 prepubertal patients with CRF (group 1), mean (range) age at start of trial 7.7 (5.0–10.4) years; 6 prepubertal patients with renal transplants (group 2), age 11.9 (9.5–14.6) years; and 6 pubertal patients with renal transplants (group 3), age 15.6 (14.1–18… CONTINUE READING